Open Label Study of Omacetaxine Mepesuccinate in Patients With Advanced CML

Study Title
Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML
Teva Identifier
CGX-635-CML-203 | 2007-001286-15
ClinicalTrials.gov Identifier
NCT00462943
Study Status
Completed
Trial Condition(s)
Chronic Myeloid Leukemia
Interventions
Drug: Omacetaxine mepesuccinate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years and older
Trial Duration
03/01/2007 - 09/01/2013
Phase
Phase 2

Study Type

Interventional